AMA
Sochal M, Krzywdzińska M, Gabryelska A, Talar-Wojnarowska R, Małecka-Panas E. Efficiency and safety of one-year anti-TNF-α treatment in Crohn’s disease: a Polish single-centre experience. Gastroenterology Review/Przegląd Gastroenterologiczny. 2020;15(2):156-160. doi:10.5114/pg.2019.90079.
APA
Sochal, M., Krzywdzińska, M., Gabryelska, A., Talar-Wojnarowska, R., & Małecka-Panas, E. (2020). Efficiency and safety of one-year anti-TNF-α treatment in Crohn’s disease: a Polish single-centre experience. Gastroenterology Review/Przegląd Gastroenterologiczny, 15(2), 156-160. https://doi.org/10.5114/pg.2019.90079
Chicago
Sochal, Marcin, Monika Krzywdzińska, Agata Gabryelska, Renata Talar-Wojnarowska, and Ewa Małecka-Panas. 2020. "Efficiency and safety of one-year anti-TNF-α treatment in Crohn’s disease: a Polish single-centre experience". Gastroenterology Review/Przegląd Gastroenterologiczny 15 (2): 156-160. doi:10.5114/pg.2019.90079.
Harvard
Sochal, M., Krzywdzińska, M., Gabryelska, A., Talar-Wojnarowska, R., and Małecka-Panas, E. (2020). Efficiency and safety of one-year anti-TNF-α treatment in Crohn’s disease: a Polish single-centre experience. Gastroenterology Review/Przegląd Gastroenterologiczny, 15(2), pp.156-160. https://doi.org/10.5114/pg.2019.90079
MLA
Sochal, Marcin et al. "Efficiency and safety of one-year anti-TNF-α treatment in Crohn’s disease: a Polish single-centre experience." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 15, no. 2, 2020, pp. 156-160. doi:10.5114/pg.2019.90079.
Vancouver
Sochal M, Krzywdzińska M, Gabryelska A, Talar-Wojnarowska R, Małecka-Panas E. Efficiency and safety of one-year anti-TNF-α treatment in Crohn’s disease: a Polish single-centre experience. Gastroenterology Review/Przegląd Gastroenterologiczny. 2020;15(2):156-160. doi:10.5114/pg.2019.90079.
